

CORDENPHARMA CAPONAGO (IT)
Core Capabilities
- >> Experts in formulating and packaging parenteral dosage forms
- >> Sterile emulsion technology
- >> Pre-filled syringes
- >> Distribution of clinical trial medication
- >> Formulation development
COMPLIANCE
- >> EMEA (AIFA)
- >> FDA
- >> ANVISA
- >> TGA
- >> Japanese MoH
Corporate Governance
Related Products & Platforms
Technology Platforms
Facility Legacy
CordenPharma Caponago is a cGMP manufacturer of a wide range of sterile liquid dosage forms for injectable use with specialised expertise in terminal sterilization, aseptic fill & finish operations and sterile emulsion technology. The site has full range of capabilities including formulation development, manufacturing, clinical trials management and packaging & pharma-logistics.
As a former AstraZeneca operations site, CordenPharma Caponago brings over 20 years of experience to CordenPharma’s full-service CDMO platform. The site is inspected by EMA (AIFA), FDA, ANVISA, TGA, and the Japanese Authority.
HISTORY
- >> 1970 Foundation
- >> 1987 Expansion to accommodate Diprivan
- >> 1991 Further expansion
- >> 1992 First FDA approval
- >> 2001 Acquired ex–Upjohn Plant
- >> 2005 New plant for Carbapenemic packaging and analysis
- >> 2007 Latest Anvisa (Brasilian) Audit
- >> 2009 Acquired by ICIG to become Corden Pharma Caponago S.p.A.
- >> 2009 Latest FDA Audit
- >> 2009 Latest Italian MoH Audit (AIFA)
- >> 2011 Italian AIFA & FDA combined audit
- >> 2012 Italian MoH Veterinary approval
- >> 2016 Italian MoH (EU) approval of New Aseptic Dept
Managing Director
Fabrizio Fiordigiglio
Corden Pharma Caponago S.p.A.
Viale dell’Industria, 3
20867 Caponago
Monza Brianza
Italy
Phone: +39 02 95452 1
Fax: +39 02 95452 300